BACKGROUND: RBC transfusion has been associated with increased morbidity and mortality in a variety of clinical settings. We assessed the effect of RBC transfusion on in-hospital mortality in patients with acute lung injury (ALI). METHODS: Cohort study of 248 consecutive patients with ALI. RBC transfusion was evaluated as both dichotomous and continuous variables, with outcome being in-hospital mortality adjusted for clinical confounders and length of total hospital stay. RESULTS: Overall in-hospital mortality rate was 39.5%. Of these patients, 207 of 248 patients (83.5%) received > or = 1 U of packed RBCs. The transfusion of any packed RBCs was associated with an increased risk of death (adjusted odds ratio [OR], 3.12; 95% confidence interval [CI], 1.28 to 7.58; p < 0.001). The overall OR per unit was 1.06 (95% CI, 1.04 to 1.09; p < 0.001) in the complete multivariable model. Transfusion after ALI onset was associated with an adjusted OR of 1.13 (95% CI, 1.07 to 1.20; p < 0.001), while transfusion before ALI onset was not associated with higher risk. The adjusted OR per unit of nonleukoreduced RBC transfused was 1.14 (95% CI, 1.07 to 1.21; p < 0.001), while the adjusted OR for leukoreduced cells per unit transfused was 1.06 (95% CI, 1.03 to 1.09; p < 0.001). CONCLUSIONS: Transfusion of RBCs in patients with ALI was associated with increased in-hospital mortality. This risk occurred with RBC transfusion after the onset of ALI, and was greater for nonleukoreduced than for leukoreduced RBCs. Aggressive transfusion strategies in patients with established ALI should be questioned, pending further study.
BACKGROUND:RBC transfusion has been associated with increased morbidity and mortality in a variety of clinical settings. We assessed the effect of RBC transfusion on in-hospital mortality in patients with acute lung injury (ALI). METHODS: Cohort study of 248 consecutive patients with ALI. RBC transfusion was evaluated as both dichotomous and continuous variables, with outcome being in-hospital mortality adjusted for clinical confounders and length of total hospital stay. RESULTS: Overall in-hospital mortality rate was 39.5%. Of these patients, 207 of 248 patients (83.5%) received > or = 1 U of packed RBCs. The transfusion of any packed RBCs was associated with an increased risk of death (adjusted odds ratio [OR], 3.12; 95% confidence interval [CI], 1.28 to 7.58; p < 0.001). The overall OR per unit was 1.06 (95% CI, 1.04 to 1.09; p < 0.001) in the complete multivariable model. Transfusion after ALI onset was associated with an adjusted OR of 1.13 (95% CI, 1.07 to 1.20; p < 0.001), while transfusion before ALI onset was not associated with higher risk. The adjusted OR per unit of nonleukoreduced RBC transfused was 1.14 (95% CI, 1.07 to 1.21; p < 0.001), while the adjusted OR for leukoreduced cells per unit transfused was 1.06 (95% CI, 1.03 to 1.09; p < 0.001). CONCLUSIONS: Transfusion of RBCs in patients with ALI was associated with increased in-hospital mortality. This risk occurred with RBC transfusion after the onset of ALI, and was greater for nonleukoreduced than for leukoreduced RBCs. Aggressive transfusion strategies in patients with established ALI should be questioned, pending further study.
Authors: Mark E Mikkelsen; Chirag V Shah; Arnaud Scherpereel; Paul N Lanken; Philippe Lassalle; Scarlett L Bellamy; A Russell Localio; Steven M Albelda; Nuala J Meyer; Jason D Christie Journal: J Crit Care Date: 2011-09-29 Impact factor: 3.425
Authors: Chirag V Shah; Paul N Lanken; A Russell Localio; Robert Gallop; Scarlett Bellamy; Shwu-Fan Ma; Carlos Flores; Jeremy M Kahn; Barbara Finkel; Barry D Fuchs; Joe G N Garcia; Jason D Christie Journal: Chest Date: 2010-06-24 Impact factor: 9.410
Authors: Jason D Christie; Chirag V Shah; Steven M Kawut; Nilam Mangalmurti; David J Lederer; Joshua R Sonett; Vivek N Ahya; Scott M Palmer; Keith Wille; Vibha Lama; Pali D Shah; Ashish Shah; Ann Weinacker; Clifford S Deutschman; Benjamin A Kohl; Ejigayehu Demissie; Scarlett Bellamy; Lorraine B Ware Journal: Am J Respir Crit Care Med Date: 2009-08-06 Impact factor: 21.405
Authors: James D Reynolds; Kyla M Bennett; Anthony J Cina; Diana L Diesen; Matthew B Henderson; Faisal Matto; Andrew Plante; Rachel A Williamson; Keivan Zandinejad; Ivan T Demchenko; Douglas T Hess; Claude A Piantadosi; Jonathan S Stamler Journal: Proc Natl Acad Sci U S A Date: 2013-06-24 Impact factor: 11.205
Authors: David J Murphy; David Howard; Angela Muriithi; Pedro Mendez-Tellez; Jonathan Sevransky; Carl Shanholtz; Giora Netzer; Peter J Pronovost; Dale M Needham Journal: Crit Care Med Date: 2009-06 Impact factor: 7.598
Authors: Katie L Lannan; Julie Sahler; Sherry L Spinelli; Richard P Phipps; Neil Blumberg Journal: Blood Cells Mol Dis Date: 2012-09-13 Impact factor: 3.039